Safety and Efficacy of CollaRx® Bupivacaine Implant in Men After Open Laparotomy Herniorrhaphy
Status:
Completed
Trial end date:
2011-05-18
Target enrollment:
Participant gender:
Summary
This study will assess pain intensity for the first 72 hrs after after aggravated movement
(cough)following open laparotomy inguinal herniorrhaphy in patient who receive either the
CollaRx Bupivacaine implant or a plain collagen sponge.